×
About 373 results

ALLMedicine™ Ebola Virus Infection Center

Research & Reviews  128 results

Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus ...
https://doi.org/10.1016/S1473-3099(22)00127-X
The Lancet. Infectious Diseases; Kelly JD, Van Ryn C et. al.

May 20th, 2022 - Whether or not individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease develop clinical sequelae is unknown. We assessed current symptoms and physical examination findings among individuals wit...

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
https://clinicaltrials.gov/ct2/show/NCT02431923

May 20th, 2022 - Between 1994 and the present, there have been several Ebola virus outbreaks affecting mostly countries in Central Africa. However, the 2014 West African outbreak significantly exceeds all previous outbreaks in geographic range and number of indivi...

Recombinant Lloviu virus as a tool to study viral replication and host responses.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849519
PLoS Pathogens; Hume AJ, Heiden B et. al.

Feb 5th, 2022 - Next generation sequencing has revealed the presence of numerous RNA viruses in animal reservoir hosts, including many closely related to known human pathogens. Despite their zoonotic potential, most of these viruses remain understudied due to not...

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licens...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745396
Emerging Microbes & Infections; Kummer S, Lander A et. al.

Dec 18th, 2021 - Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). The latest occasional EVD outbreak (2013-2016) in Western African, which was accompanied by a high fatality rate, showed the great potential of epide...

Convalescent Plasma Trial in COVID -19 Patients
https://clinicaltrials.gov/ct2/show/NCT04356534

Oct 26th, 2021 - Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a pandemic with serious global public health and economic sequelae. As of March 30, 2020, over 750,000 cases h...

see more →

Clinicaltrials.gov  2 results

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
https://clinicaltrials.gov/ct2/show/NCT02431923

May 20th, 2022 - Between 1994 and the present, there have been several Ebola virus outbreaks affecting mostly countries in Central Africa. However, the 2014 West African outbreak significantly exceeds all previous outbreaks in geographic range and number of indivi...

Convalescent Plasma Trial in COVID -19 Patients
https://clinicaltrials.gov/ct2/show/NCT04356534

Oct 26th, 2021 - Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a pandemic with serious global public health and economic sequelae. As of March 30, 2020, over 750,000 cases h...

see more →

News  19 results

Certain Biomarkers May Distinguish Ebola Fatalities From Survivors
https://www.medscape.com/viewarticle/889171

Nov 28th, 2017 - NEW YORK (Reuters Health) – Newly identified biomarkers may be able to distinguish fatal from nonfatal Ebola infections, ultimately enabling clinicians to prioritize scarce treatment resources, researchers suggest. Dr. Yoshihiro Kawaoka of the Uni...

Ebola research update: August 2016
https://www.mdedge.com/infectiousdisease/article/113862/international-id/ebola-research-update-august-2016
Richard Pizzi

Sep 23rd, 2016 - The struggle to defeat Ebola virus disease continues globally, although it may not always make the headlines. To catch up on what you may have missed, here are some notable news items and journal articles published over the past few weeks that are.

Ebola research update: February 2016
https://www.mdedge.com/infectiousdisease/article/107208/international-id/ebola-research-update-february-2016
Richard Pizzi

Mar 8th, 2016 - The struggle to defeat Ebola viral disease continues globally, although it may not always make the headlines. To catch up on what you may have missed, here are some notable news items and journal articles published over the past few weeks that are.

Ebola patients treated in the West showed 81.5% survival
https://www.mdedge.com/familymedicine/article/106575/international-id/ebola-patients-treated-west-showed-815-survival
Infectious Disease Practitioner; Mary Ann Moon

Feb 17th, 2016 - Overall survival was 81. 5% for the 27 patients with Ebola virus infection who were treated in the United States or Europe during the recent outbreak, according to a report published online Feb.

Ebola patients treated in the West showed 81.5% survival
https://www.mdedge.com/chestphysician/article/106575/international-id/ebola-patients-treated-west-showed-815-survival
Mary Ann Moon, MDedge News

Feb 17th, 2016 - Overall survival was 81. 5% for the 27 patients with Ebola virus infection who were treated in the United States or Europe during the recent outbreak, according to a report published online Feb.

see more →